205 related articles for article (PubMed ID: 35766055)
1. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology.
Hall J; Bourne KM; Vernino S; Hamrefors V; Kharraziha I; Nilsson J; Sheldon RS; Fedorowski A; Raj SR
Circulation; 2022 Aug; 146(8):613-622. PubMed ID: 35766055
[TBL] [Abstract][Full Text] [Related]
2. Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome.
Kharraziha I; Axelsson J; Ricci F; Di Martino G; Persson M; Sutton R; Fedorowski A; Hamrefors V
J Am Heart Assoc; 2020 Aug; 9(15):e015989. PubMed ID: 32750291
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune basis for postural tachycardia syndrome.
Li H; Yu X; Liles C; Khan M; Vanderlinde-Wood M; Galloway A; Zillner C; Benbrook A; Reim S; Collier D; Hill MA; Raj SR; Okamoto LE; Cunningham MW; Aston CE; Kem DC
J Am Heart Assoc; 2014 Feb; 3(1):e000755. PubMed ID: 24572257
[TBL] [Abstract][Full Text] [Related]
4. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies.
Gunning WT; Kvale H; Kramer PM; Karabin BL; Grubb BP
J Am Heart Assoc; 2019 Sep; 8(18):e013602. PubMed ID: 31495251
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
[TBL] [Abstract][Full Text] [Related]
6. Antiadrenergic autoimmunity in postural tachycardia syndrome.
Fedorowski A; Li H; Yu X; Koelsch KA; Harris VM; Liles C; Murphy TA; Quadri SMS; Scofield RH; Sutton R; Melander O; Kem DC
Europace; 2017 Jul; 19(7):1211-1219. PubMed ID: 27702852
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome.
Sunami Y; Sugaya K; Takahashi K
Immunol Med; 2024 Jun; ():1-8. PubMed ID: 38900132
[TBL] [Abstract][Full Text] [Related]
8. Association of autoantibodies to muscarinic acetylcholine receptors with gastrointestinal symptoms and disease severity in patients with postural orthostatic tachycardia syndrome.
Sunami Y; Sugaya K; Miyakoshi N; Iwazaki O; Takahashi K
Immunol Res; 2022 Apr; 70(2):197-207. PubMed ID: 34993884
[TBL] [Abstract][Full Text] [Related]
9. Implications of Antimuscarinic Autoantibodies in Postural Tachycardia Syndrome.
Li H; Zhang G; Forsythe E; Okamoto LE; Yu X
J Cardiovasc Transl Res; 2022 Apr; 15(2):438-440. PubMed ID: 34409582
[TBL] [Abstract][Full Text] [Related]
10. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies.
Knoop I; Picariello F; Jenkinson E; Gall N; Chisari C; Moss-Morris R
Auton Neurosci; 2023 Jan; 244():103052. PubMed ID: 36525900
[TBL] [Abstract][Full Text] [Related]
11. Postural orthostatic tachycardia syndrome as a sequela of COVID-19.
Ormiston CK; Świątkiewicz I; Taub PR
Heart Rhythm; 2022 Nov; 19(11):1880-1889. PubMed ID: 35853576
[TBL] [Abstract][Full Text] [Related]
12. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.
Raj SR; Guzman JC; Harvey P; Richer L; Schondorf R; Seifer C; Thibodeau-Jarry N; Sheldon RS
Can J Cardiol; 2020 Mar; 36(3):357-372. PubMed ID: 32145864
[TBL] [Abstract][Full Text] [Related]
13. Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome.
Spahic JM; Hamrefors V; Johansson M; Ricci F; Melander O; Sutton R; Fedorowski A
J Intern Med; 2023 Jan; 293(1):91-99. PubMed ID: 36111700
[TBL] [Abstract][Full Text] [Related]
14. Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?
Blitshteyn S
J Neurol; 2022 Feb; 269(2):725-732. PubMed ID: 33677650
[TBL] [Abstract][Full Text] [Related]
15. Platelet Storage Pool Deficiency and Elevated Inflammatory Biomarkers Are Prevalent in Postural Orthostatic Tachycardia Syndrome.
Gunning WT; Kramer PM; Cichocki JA; Karabin BL; Khuder SA; Grubb BP
Cells; 2022 Feb; 11(5):. PubMed ID: 35269395
[TBL] [Abstract][Full Text] [Related]
16. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.
Vernino S; Bourne KM; Stiles LE; Grubb BP; Fedorowski A; Stewart JM; Arnold AC; Pace LA; Axelsson J; Boris JR; Moak JP; Goodman BP; Chémali KR; Chung TH; Goldstein DS; Diedrich A; Miglis MG; Cortez MM; Miller AJ; Freeman R; Biaggioni I; Rowe PC; Sheldon RS; Shibao CA; Systrom DM; Cook GA; Doherty TA; Abdallah HI; Darbari A; Raj SR
Auton Neurosci; 2021 Nov; 235():102828. PubMed ID: 34144933
[TBL] [Abstract][Full Text] [Related]
17. Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance.
Garland EM; Celedonio JE; Raj SR
Curr Neurol Neurosci Rep; 2015 Sep; 15(9):60. PubMed ID: 26198889
[TBL] [Abstract][Full Text] [Related]
18. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review.
Ruzieh M; Batizy L; Dasa O; Oostra C; Grubb B
Scand Cardiovasc J; 2017 Oct; 51(5):243-247. PubMed ID: 28738696
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of cerebral oximetry in patients with postural orthostatic tachycardia syndrome.
Kharraziha I; Holm H; Bachus E; Melander O; Sutton R; Fedorowski A; Hamrefors V
Europace; 2019 Oct; 21(10):1575-1583. PubMed ID: 31384930
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome.
Medic Spahic J; Ricci F; Aung N; Hallengren E; Axelsson J; Hamrefors V; Melander O; Sutton R; Fedorowski A
BMC Cardiovasc Disord; 2020 Apr; 20(1):190. PubMed ID: 32321428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
